These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3918588)

  • 1. A placebo-controlled trial of valproate in tardive dyskinesia.
    Nasrallah HA; Dunner FJ; McCalley-Whitters M
    Biol Psychiatry; 1985 Feb; 20(2):205-8. PubMed ID: 3918588
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of sodium valproate on tardive dyskinesia--revisited.
    Fisk GG; York SM
    Br J Psychiatry; 1987 Apr; 150():542-6. PubMed ID: 3117156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium valproate in tardive dyskinesia.
    Casey DE; Hammerstad JP
    J Clin Psychiatry; 1979 Nov; 40(11):483-5. PubMed ID: 385585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium valproate and tardive dyskinesia.
    Gibson AC
    Br J Psychiatry; 1978 Jul; 133():82. PubMed ID: 352469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.
    Nair NP; Lal S; Schwartz G; Thavundayil JX
    Adv Biochem Psychopharmacol; 1980; 24():437-41. PubMed ID: 6773303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium valproate and tardive dyskinesia.
    Linnoila M; Viukari M
    Br J Psychiatry; 1979 Feb; 134():223-4. PubMed ID: 371732
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium valproate and tardive dyskinesia.
    Ames D; Webber J
    Med J Aust; 1984 Mar; 140(6):350. PubMed ID: 6422217
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium valproate in the treatment of levodopa-induced dyskinesia.
    Price PA; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):702-6. PubMed ID: 355601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
    Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE
    J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
    Chien C; Jung K; Ross-Townsend A
    Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102
    [No Abstract]   [Full Text] [Related]  

  • 11. GABA system: clinical research and treatment of tardive dyskinesia.
    Thaker GK; Hare TA; Tamminga CA
    Mod Probl Pharmacopsychiatry; 1983; 21():155-67. PubMed ID: 6419061
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid.
    Ogawa T; Nagao T; Kashiwabara K; Fujiwara Y; Harada T; Otsuki S
    Clin Ther; 1984; 7 Spec No():1-17. PubMed ID: 6085032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo.
    Friis T; Christensen TR; Gerlach J
    Acta Psychiatr Scand; 1983 Mar; 67(3):178-87. PubMed ID: 6134430
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement in tardive dyskinesia with aripiprazole use.
    Witschy JK; Winter AS
    Can J Psychiatry; 2005 Mar; 50(3):188. PubMed ID: 15830835
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulpiride in tardive dyskinesia.
    Casey DE; Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxypertine in tardive dyskinesia: an 8-week controlled study.
    Soni SD; Freeman HL; Hussein EM
    Br J Psychiatry; 1984 Jan; 144():48-52. PubMed ID: 6140973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium in tardive dyskinesia.
    Simpson GM; Branchey MH; Lee JH; Voitashevsky A; Zoubok B
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Mar; 9(2):76-80. PubMed ID: 790411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of sodium valproate in severe epilepsy.
    Richens A; Ahmad S
    Br Med J; 1975 Nov; 4(5991):255-6. PubMed ID: 1104059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.